Perrigo Company PLC (PRGO)
Official siteHEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NYSE
Market Cap: $2.25B
Last updated: Nov 17, 2026 at 11:06 AM ET
Perrigo Company PLC (PRGO) Financials: Revenue, Profit and Cash Flow
Perrigo Company reported revenue of $4.25B for the fiscal year ended Dec 31, 2025, down 2.8% from the year before. That year, net income was -$1.43B with a net margin of -33.5%, operating cash flow was $238.50M and free cash flow was $145.10M. The quarter ended Sep 30, 2026 had revenue of $988.60M and net income of -$27.50M.
Revenue and Margins
The operating margin was 8.1% in the fiscal year ended Dec 2025. Over the 9 years to Dec 2025, revenue fell from $5.28B, a compound annual decline of 2.4%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $4.25B | -2.8% | 35.1% | 8.1% | -33.5% |
| Dec 2024 | $4.37B | -6.1% | 35.3% | 2.6% | -3.9% |
| Dec 2023 | $4.66B | +4.6% | 36.1% | 3.3% | -0.3% |
| Dec 2022 | $4.45B | +7.6% | 32.7% | 1.8% | -3.2% |
| Dec 2021 | $4.14B | +1.2% | 34.2% | 9.9% | -1.7% |
| Dec 2020 | $4.09B | +5.6% | 36.6% | 6.5% | -4.0% |
| Dec 2019 | $3.87B | -18.2% | 37.0% | 4.5% | 3.8% |
| Dec 2018 | $4.73B | -4.3% | 38.7% | 5.0% | 2.8% |
| Dec 2017 | $4.95B | -6.3% | 40.0% | 12.1% | 2.4% |
| Dec 2016 | $5.28B | N/A | 38.9% | -37.9% | -76.0% |
Income Statement
In the fiscal year ended Dec 2025, the net loss widened from the year before. In the quarter ended Sep 2026, the company posted a net loss after a profit in the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.25B | $4.37B | $4.66B | $4.45B | $4.14B | $4.09B | $3.87B | $4.73B | $4.95B | $5.28B |
| Cost of revenue | $2.76B | $2.83B | $2.98B | $3.00B | $2.72B | $2.59B | $2.44B | $2.90B | $2.97B | $3.23B |
| Gross profit | $1.49B | $1.54B | $1.68B | $1.46B | $1.42B | $1.49B | $1.43B | $1.83B | $1.98B | $2.05B |
| Research and development | $95.40M | $112.20M | $122.50M | $123.10M | $122.00M | $121.70M | $119.20M | $218.60M | $167.70M | $184.00M |
| Operating income | $343.30M | $112.90M | $151.90M | $78.90M | $410.40M | $265.20M | $174.70M | $236.50M | $598.20M | -$2.00B |
| Net income | -$1.43B | -$171.80M | -$12.70M | -$140.60M | -$68.90M | -$162.60M | $146.10M | $131.00M | $119.60M | -$4.01B |
| EBITDA | N/A | $433.00M | $525.00M | $355.50M | $695.90M | $518.40M | $662.00M | $906.00M | $1.14B | N/A |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $988.60M | $1.02B | $969.20M | $1.11B | $1.04B | $1.06B | $1.04B | $1.14B | $1.09B | $1.07B | $1.08B | $1.16B |
| Gross profit | $320.80M | $313.90M | $325.50M | $362.20M | $377.10M | $362.90M | $392.30M | $385.90M | $404.40M | $394.70M | $357.70M | $427.30M |
| Operating income | $23.10M | $23.50M | $34.20M | $84.70M | $72.60M | $45.40M | $46.90M | $114.20M | $80.40M | -$26.50M | -$55.20M | -$15.60M |
| Net income | -$27.50M | $74.50M | -$398.60M | -$1.42B | $7.50M | -$8.40M | -$6.40M | -$44.50M | -$21.00M | -$108.40M | $2.00M | -$32.30M |
Balance Sheet
As of Dec 2025, total debt of $3.67B exceeded cash and equivalents by $3.13B.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $8.54B | $9.65B | $10.81B | $11.02B | $10.43B | $11.49B | $11.30B | $10.98B | $11.63B | $13.87B |
| Current assets | $2.80B | $2.48B | $2.83B | $2.72B | $3.86B | $3.13B | $2.73B | $2.90B | $2.82B | $2.81B |
| Cash and equivalents | $531.60M | $558.80M | $751.30M | $600.70M | $1.86B | $631.50M | $354.30M | $551.10M | $678.70M | $622.30M |
| Total liabilities | $5.60B | $5.33B | $6.04B | $6.18B | $5.27B | $5.83B | $5.50B | $5.32B | $5.46B | $7.91B |
| Short-term debt | $62.30M | $36.40M | $440.60M | $64.60M | $629.80M | $65.60M | $3.40M | $190.20M | $70.40M | $572.80M |
| Long-term debt | $3.60B | $3.58B | $3.63B | $4.07B | $2.92B | $3.53B | $3.37B | $3.05B | $3.27B | $5.22B |
| Shareholder equity | $2.94B | $4.32B | $4.77B | $4.84B | $5.15B | $5.66B | $5.80B | $5.67B | $6.17B | $5.96B |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $7.48B | $7.61B | $7.98B | $8.54B | $10.08B | $10.09B | $9.76B | $9.65B | $11.20B | $10.40B | $10.64B | $10.81B |
| Total liabilities | $5.04B | $5.09B | $5.48B | $5.60B | $5.64B | $5.62B | $5.40B | $5.33B | $6.64B | $5.85B | $5.95B | $6.04B |
| Cash and equivalents | $436.60M | $399.70M | $357.20M | $531.60M | $432.10M | $454.20M | $409.90M | $558.80M | $1.46B | $538.10M | $651.50M | $751.30M |
| Shareholder equity | $2.44B | $2.52B | $2.50B | $2.94B | $4.45B | $4.47B | $4.36B | $4.32B | $4.57B | $4.55B | $4.69B | $4.77B |
Cash Flow
In the fiscal year ended Dec 2025, free cash flow was 60.8% of operating cash flow. Dividends came to 109.8% of it.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $238.50M | $362.90M | $405.50M | $307.30M | $156.30M | $636.20M | $387.80M | $593.00M | $698.90M | $654.90M |
| Capital expenditures | $93.40M | $118.30M | $101.70M | $96.40M | $152.10M | $170.40M | $137.70M | $102.60M | $88.60M | $106.20M |
| Free cash flow | $145.10M | $244.60M | $303.80M | $210.90M | $4.20M | $465.80M | $250.10M | $490.40M | $610.30M | $548.70M |
| Dividends paid | $159.30M | $152.50M | $149.70M | $142.40M | $129.60M | $123.90M | $112.40M | $104.90M | $91.10M | $83.20M |
| Investing cash flow | -$75.40M | $78.80M | -$77.50M | -$1.96B | $1.28B | -$187.80M | -$596.10M | -$126.80M | $2.34B | -$175.00M |
| Financing cash flow | -$220.50M | -$611.00M | -$187.20M | $421.60M | -$178.70M | -$181.10M | $1.80M | -$571.90M | -$3.00B | -$268.70M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $96.20M | $138.30M | -$113.60M | $175.40M | $51.70M | $75.90M | -$64.50M | $312.60M | $42.20M | $9.50M | -$1.40M | $208.70M |
| Capital expenditures | $17.50M | $14.30M | $13.80M | $26.80M | $21.90M | $19.20M | $25.50M | $37.70M | $27.10M | $28.40M | $25.10M | $26.70M |
| Free cash flow | $78.70M | $124.00M | -$127.40M | $148.60M | $29.80M | $56.70M | -$90.00M | $274.90M | $15.10M | -$18.90M | -$26.50M | $182.00M |
Frequently Asked Questions About PRGO
What is Perrigo Company's annual revenue?
Perrigo Company reported revenue of $4.25B for the fiscal year ended Dec 31, 2025.
How fast is Perrigo Company's revenue growing?
Revenue was down 2.8% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was -1.5%.
Is Perrigo Company profitable?
No. Perrigo Company reported net income of -$1.43B for the fiscal year ended Dec 31, 2025, with a net margin of -33.5%.
How much free cash flow does PRGO generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of $238.50M minus capital expenditures of $93.40M produced free cash flow of $145.10M.
How much debt does Perrigo Company have?
The balance sheet dated Dec 31, 2025 reported long-term debt of $3.60B, short-term debt of $62.30M and cash and equivalents of $531.60M.
PRGO pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors